Skip to content

Incyte INCY PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$7.79B+5.7%
Pfizer logo
PfizerPFE
$19.4B+5.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.4M+60.7%
Gilead Sciences logo
Gilead SciencesGILD
$5.64B+4.0%
Geron logo
GeronGERN
$1M-12.8%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$3.78M+7.0%

Segments

By geography

See full
Other countries$13.04M-6.5%

Other financials

Income statement

See full
Revenue$1.7B+37.7%
Gross profit$1.6B+38.0%
Operating income$697.9M+31.6%
Net income$585.6M+44.6%
EPS (diluted)$2.81+37.7%

Balance sheet

See full
Cash & equivalents$4.0B+104%
Total debt$38.3M-9.8%
Total equity$6.3B+52.1%
Total assets$7.9B+35.2%

Cash flow

See full
Operating cash flow$507.7M+1,035%
CapEx$1.6M-43.5%
Free cash flow$509.3M+1,069%

Valuation

See full
Market cap$25.96B+70.1%
Enterprise value$22.01B+64.9%
P/E16.1×-1.4×
P/S4.5×+1.1×

Profitability

See full
Gross margin92.6%-0.3pp
Operating margin30.6%+4.8pp
Net margin27.7%+8.7pp
FCF margin34%+12.3pp

Returns & leverage

See full
Return on equity30.7%+6.4pp
Debt / equity0.0×
Current ratio4.6×+1.7×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Incyte’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's PP&E (net)?
Incyte (INCY) reported PP&E (net) of $709.47M in Q2 2026.
How has Incyte's PP&E (net) changed year-over-year?
Incyte's PP&E (net) decreased by 11.2% year-over-year, from $798.54M to $709.47M.
What is the long-term trend for Incyte's PP&E (net)?
Over 5 years (2020 to 2025), Incyte's PP&E (net) has grown at a 5.5% compound annual growth rate (CAGR), from $559.63M to $730.89M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.